Serum free light chains and multiple myeloma: Is it time to extend their application?
oleh: Uros Markovic, Valerio Leotta, Daniele Tibullo, Rachele Giubbolini, Alessandra Romano, Vittorio Del Fabro, Nunziatina Laura Parrinello, Maria Teresa Cannizzaro, Francesco Di Raimondo, Concetta Conticello
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2020-04-01 |
Deskripsi
Abstract In nonsecretory, oligo‐secretory, and light chain multiple myeloma patients, serial sFLC evaluation could precede biochemical and clinical disease progression, even in extramedullary relapse, thus initiating early treatment with novel anti‐MM agents.